Use of intravenous flunitrazepam. Minimal dose for loss of conciousness
Cormani, A.M.; Salmoiraghi, M.L.; Latini, P.; Rumeltt, S.
Minerva Anestesiologica 47(7): 413-420
1981
ISSN/ISBN: 0375-9393 PMID: 9949854 Document Number: 169247
Document emailed within 1 workday
Related Documents
Senryo, A.; Marukawa, S.; Yasumoto, R.; Shirakawa, J.; Takagi, M.; Kotake, C.; Iwai, S. 1981: Clinical evaluation of a technique using flunitrazepam for induction and low-dose ketamine microdrip for maintenance MASUI. Japanese Journal of Anesthesiology 30(7): 725-731Dagrosa, E.E.; Hajdú, P.; Malerczyk, V.; de Looze, S.; Seeger, K.; Grötsch, H. 1987: Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration Clinical Therapeutics 10(1): 18-31
Chen, C.L.; Chen, Y.S.; de Villa, V.H.; Wang, C.C.; Lin, C.L.; Goto, S.; Wang, S.H.; Cheng, Y.F.; Huang, T.L.; Jawan, B.; Cheung, H.K. 2000: Minimal blood loss living donor hepatectomy Transplantation 69(12): 2580-2586
Arokina, N.K.; Fedorov, G.S. 2009: Assessment of the minimal dose of Na2.EDTA that stimulates respiratory function in rats in hypothermia Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 95(7): 779-785
Abetel, G. 1988: The blood pressure profile, or how to establish the minimal effective dose of an antihypertensive agent Revue Medicale de la Suisse Romande 108(6): 529-533
Hamada, I.; Kato, M.; Okada, K. 2002: Multi-cytokine therapy for advanced renal cell carcinoma: determination of the minimal effective dose Anticancer Research 22(4): 2429-2436
Motolese, M. 1970: Factorial design in a balanced incomplete block in the evaluation of the minimal active dose of a beta-blocking drug Bollettino Chimico Farmaceutico 109(6): 363-368
Sapir, T.; Carp, H.; Shoenfeld, Y. 2005: Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL) Harefuah 144(6): 415
Ham, J.M. 1980: Ultra-low dose intravenous heparin Lancet 2(8184): 36
Rey, R.H.; Masnatta, L.D.; Pirola, D.; Cuniberti, L.A.; Maceira, C.; Werba, J.P. 1996: Repeatability of insulin sensitivity estimation using the Minimal Model and comparison with a modified short low-dose insulin tolerance test Medicina 56(6): 650-656
Taneichi, H.; Miyawaki, T. 2011: High-dose intravenous immunoglobulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 69(3): 515-519
Turco, S.J. 1978: Intravenous piggyback--a new dimension in unit dose Journal of the Parenteral Drug Association 32(1): 50-53
Wyse, D.G. 1982: Electrophysiologic effects of low dose intravenous sulfinpyrazone in man Proceedings of the Western Pharmacology Society 25: 289-291
Craig, T.J.; Davis, W. 1993: Hepatitis associated with high dose intravenous gammaglobulin Annals of Allergy 71(3): 276
Popa, M.I.; Stavri, D.; Stavri, H.; Popal, L.G.; Mihai, I. 2006: Establishing of a minimal set of tests (minimal standards) to identify species included in the genus Mycobacterium Roumanian Archives of Microbiology and Immunology 65(1-2): 41-45
Chug, K.S. 1976: Focal and segmental glomerular sclerosis-minimal or not-so-minimal glomerulonephritis Journal of the Association of Physicians of India 24(5): 317-319
Gibson, J.; Laird, P.P.; Joshua, D.E.; Child, A.; Harris, J.; Kronenberg, H. 1989: Very high dose intravenous gammaglobulin in thrombocytopenia of pregnancy Australian and New Zealand Journal of Medicine 19(2): 151-153
Philalithis, P.E.; Joekes, A.M. 1974: High dose intravenous prednisolone in the treatment of glomerulonephritis Journal d'Urologie et de Nephrologie 80(12): 983-984
Korsak, J.; Zaleska, B.; Orłowska, E.; Kotowicz, J. 2005: Use of high dose intravenous immunoglobulin in neurologic disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(109): 98-101
Gökşen, D.; Coker, M.; Darcan, S.ük.; Köse, T.; Kara, S. 2006: Low-dose intravenous pamidronate treatment in osteogenesis imperfecta Turkish Journal of Pediatrics 48(2): 124-129